(Q44549974)

4 December 2017

title

BRAF mutations in chronic lymphocytic leukemia (English)

1 reference

4 December 2017

0 references

1 reference

6

Stephan Stilgenbauer

0 references

Hartmut Döhner

5

object named as

Hartmut Döhner

1 reference

4 December 2017

7

Thorsten Zenz

1 reference

4 December 2017

author name string

Billy Michael Chelliah Jebaraj

1

1 reference

4 December 2017

Dirk Kienle

2

1 reference

4 December 2017

Andreas Bühler

3

1 reference

4 December 2017

Dirk Winkler

4

1 reference

4 December 2017

publication date

20 November 2012

1 reference

4 December 2017

1 reference

4 December 2017

volume

54

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

1177-1182

1 reference

Chronic lymphocytic leukemia

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

BRAF mutations in hairy-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

The T1790A BRAF mutation (L597Q) in childhood acute lymphoblastic leukemia is a functional oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

Genomic aberrations and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

BRAF inhibition in refractory hairy-cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.742525

10.3109/10428194.2012.742525

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference